SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-322731
Filing Date
2018-11-08
Accepted
2018-11-08 17:28:04
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d638110d10q.htm 10-Q 826811
2 EX-10.1 d638110dex101.htm EX-10.1 39328
3 EX-31.1 d638110dex311.htm EX-31.1 7163
4 EX-31.2 d638110dex312.htm EX-31.2 7008
5 EX-32.1 d638110dex321.htm EX-32.1 3693
6 EX-32.2 d638110dex322.htm EX-32.2 3747
13 GRAPHIC g638110dsp01.jpg GRAPHIC 4314
14 GRAPHIC g638110g1107223530430.jpg GRAPHIC 72192
  Complete submission text file 0001193125-18-322731.txt   3562725

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cnst-20180930.xml EX-101.INS 524835
8 XBRL TAXONOMY EXTENSION SCHEMA cnst-20180930.xsd EX-101.SCH 41242
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20180930_cal.xml EX-101.CAL 53522
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20180930_def.xml EX-101.DEF 117930
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20180930_lab.xml EX-101.LAB 305119
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20180930_pre.xml EX-101.PRE 219331
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 181170758
SIC: 2834 Pharmaceutical Preparations